Manus Neurodynamica’s CEO, Dr Rutger Zietsma presented to the Parkinson’s community at the Future of Parkinson’s Disease conference that was held November 30 – December 3, in Austin, Texas, US. The joint annual conference is hosted by the Parkinson’s Foundation and the Parkinson Study Group. During the Industry Iorum on the 1st of December, Dr Rutger Zietsma, introduced the … Read more
We were honoured to attend the Prix Galien USA 2023 awards ceremony on the 26th of October 2023 in New York. The Prix Galien Awards commemorate unique medical and pharmaceutical products that impact patient care through innovation. Manus Neurodynamica was one of the nominees in the start-up category. We are grateful for the recognition of … Read more
Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM Parkinson’s disease (PD) is a progressive neurological condition associated with dysfunction of the extrapyramidal system. The cardinal symptoms of PD are bradykinesia (slowness of movement), rest tremor (shaking … Read more
Name:Roman Bauer1, Rutger Zietsma1, Antti Tolonen2, Luc Cluitmans2, Mark van Gils2, Keith Gray3, Richard Walker3 1. Manus Neurodynamica Ltd, Edinburgh, UK 2. Technical Research Centre of Finland (VTT), Tampere, Finland 3. Northumbria Healthcare NHS Foundation Trust, North Shields, UK An easily performed and objective test of fine motor skills would be valuable in the diagnosis of … Read more